AbstractAn increased incidence of Mycoplasma pneumoniae infections was reported in 2011 in two cities in France, Bordeaux and Caen. Two complementary molecular typing methods, PCR-RFLP on adhesin P1 and multilocus variable number tandem repeat analysis (MLVA), were used to determine whether this phenomenon was clonal. In 2011, the percentage of M. pneumoniae-positive patients doubled in both cities compared with 2010. Macrolide resistance remained stable at 8.3% of patients. Eighteen MLVA types were identified among 94 M. pneumoniae-positive specimens, demonstrating that the phenomenon was multiclonal. Types P, J, U, X and E were the most frequent and 81.6% of the strains were adhesin P1 type 1
This work was funded by Public Health England. These studies were supported by funding initiatives b...
Mycoplasma pneumoniae (MP) causes community-acquired pneumonia affecting mainly children, and tends ...
Mycoplasma pneumoniae is a leading cause of respiratory infections, including community-acquired pne...
AbstractAn increased incidence of Mycoplasma pneumoniae infections was reported in 2011 in two citie...
Mycoplasma pneumoniae infections occur both endemically and epidemically, and macrolide resistance h...
Mycoplasma pneumoniae infections occur both endemically and epidemically, and macrolide resistance h...
Mycoplasma pneumoniae infections occur both endemically and epidemically, and macrolide resistance h...
Mycoplasma pneumoniae is a respiratory bacterial pathogen causing upper and lower respiratory diseas...
Mycoplasma pneumoniae is a respiratory bacterial pathogen causing upper and lower respiratory diseas...
Macrolide-resistant Mycoplasma pneumoniae (MR-MP) is an increasing problem worldwide. This study des...
Mycoplasma pneumoniae causes respiratory infections, such as community-acquired pneumonia (CAP), wit...
Mycoplasma pneumoniae causes respiratory infections, such as community-acquired pneumonia (CAP), wit...
Macrolide-resistant Mycoplasma pneumoniae (MR-MP) is an increasing problem worldwide. This study des...
Macrolide-resistant Mycoplasma pneumoniae (MRMP) is rapidly emerging in Asia, but information on the...
AbstractTyping of Mycoplasma pneumoniae by multiple-locus variable-number tandem repeat analysis (ML...
This work was funded by Public Health England. These studies were supported by funding initiatives b...
Mycoplasma pneumoniae (MP) causes community-acquired pneumonia affecting mainly children, and tends ...
Mycoplasma pneumoniae is a leading cause of respiratory infections, including community-acquired pne...
AbstractAn increased incidence of Mycoplasma pneumoniae infections was reported in 2011 in two citie...
Mycoplasma pneumoniae infections occur both endemically and epidemically, and macrolide resistance h...
Mycoplasma pneumoniae infections occur both endemically and epidemically, and macrolide resistance h...
Mycoplasma pneumoniae infections occur both endemically and epidemically, and macrolide resistance h...
Mycoplasma pneumoniae is a respiratory bacterial pathogen causing upper and lower respiratory diseas...
Mycoplasma pneumoniae is a respiratory bacterial pathogen causing upper and lower respiratory diseas...
Macrolide-resistant Mycoplasma pneumoniae (MR-MP) is an increasing problem worldwide. This study des...
Mycoplasma pneumoniae causes respiratory infections, such as community-acquired pneumonia (CAP), wit...
Mycoplasma pneumoniae causes respiratory infections, such as community-acquired pneumonia (CAP), wit...
Macrolide-resistant Mycoplasma pneumoniae (MR-MP) is an increasing problem worldwide. This study des...
Macrolide-resistant Mycoplasma pneumoniae (MRMP) is rapidly emerging in Asia, but information on the...
AbstractTyping of Mycoplasma pneumoniae by multiple-locus variable-number tandem repeat analysis (ML...
This work was funded by Public Health England. These studies were supported by funding initiatives b...
Mycoplasma pneumoniae (MP) causes community-acquired pneumonia affecting mainly children, and tends ...
Mycoplasma pneumoniae is a leading cause of respiratory infections, including community-acquired pne...